Form4insider filings, from the source

SEC Form 4 · accession 0001178913-18-000261

Foamix Pharmaceuticals Ltd. · FOMX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Alvin D Howard
Officer — VP Regulatory
Period of report
Jan 1, 2018
Accepted (ET)
Jan 24, 2018 · 8:22 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001606645

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Ordinary SharesF1,F2Jan 1, 2018M2,288$0.00A35,915D
Ordinary SharesF3Jan 2, 2018F924$5.98D34,991D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Restricted Share UnitsF1,F5,F4$0.00Jan 1, 2018M2,288D——Ordinary Shares2,2880D

Explanation of responses